Urothelial Cancer
A Phase 1/2 Study to Investigate the Safety, Pharmacokinetics, and Efficacy of CRB-701, an Antibody Drug Conjugate Targeting Nectin-4, in Patients with Advanced Solid Tumors (CRB-701-01)
- Details
ClinicalTrials.gov ID:
NCT06265727
Diagnosis Type:
NA
USOR Number:
- Address
,
P: